Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Glemorstart-M V 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Dd Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glemorstart-M V 2 Tablet SR

Diabex Duo SR tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabex Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms such as sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Diabex Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Glemorstart-M V 2 Tablet SR

No text provided. Please provide the text you wish to be rewritten.

Uses of Glemorstart-M V 2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glemorstart-M V 2 Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Glemorstart-M V 2 Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication on an empty stomach.

Common Side effects of Glemorstart-M V 2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glemorstart-M V 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glemorstart-M V 2 Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Glemorstart-M V 2 Tablet SR works:

Extended-release Glemorstart-M V2 tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glemorstart-M V 2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glemorstart-M V 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glemorstart-M V 2 Tablet likely poses a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with the possibility of adverse effects on the nursing child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Glemorstart-M V 2 Tablet SR is likely inadvisable for individuals with impaired kidney function and should be omitted. Medical guidance is recommended. Furthermore, its use is contraindicated in patients exhibiting severe renal dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glemorstart-M V 2 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glemorstart-M V 2 Tablet SR :

Should you forget to take a Glemorstart-M V 2 Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glemorstart-M V 2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glemorstart-M V 2 Tablet SR

Glemorstart-M V 2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Glemorstart-M V 2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glemorstart-M V 2 Tablet SR is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Glemorstart-M V 2 Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glemorstart-M V 2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions provided. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Glemorstart-M V 2 Tablet ...
119
MRP 138
13% off